CA2645318A1 - Compositions pharmaceutiques contenant de la metformine - Google Patents

Compositions pharmaceutiques contenant de la metformine Download PDF

Info

Publication number
CA2645318A1
CA2645318A1 CA002645318A CA2645318A CA2645318A1 CA 2645318 A1 CA2645318 A1 CA 2645318A1 CA 002645318 A CA002645318 A CA 002645318A CA 2645318 A CA2645318 A CA 2645318A CA 2645318 A1 CA2645318 A1 CA 2645318A1
Authority
CA
Canada
Prior art keywords
metformin
glimepiride
patient
hydrochloride
formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002645318A
Other languages
English (en)
Inventor
Krishna Vishnupad
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NEUROSCI Inc
Original Assignee
Neurosci, Inc.
Krishna Vishnupad
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurosci, Inc., Krishna Vishnupad filed Critical Neurosci, Inc.
Publication of CA2645318A1 publication Critical patent/CA2645318A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
CA002645318A 2006-03-09 2007-03-09 Compositions pharmaceutiques contenant de la metformine Abandoned CA2645318A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US78094406P 2006-03-09 2006-03-09
US60/780,944 2006-03-09
PCT/US2007/006055 WO2007103563A2 (fr) 2006-03-09 2007-03-09 Compositions pharmaceutiques contenant de la metformine

Publications (1)

Publication Number Publication Date
CA2645318A1 true CA2645318A1 (fr) 2007-09-13

Family

ID=38475600

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002645318A Abandoned CA2645318A1 (fr) 2006-03-09 2007-03-09 Compositions pharmaceutiques contenant de la metformine

Country Status (3)

Country Link
EP (1) EP2001302A2 (fr)
CA (1) CA2645318A1 (fr)
WO (1) WO2007103563A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110801443A (zh) * 2019-12-03 2020-02-18 仁和堂药业有限公司 一种盐酸二甲双胍缓释制剂及其质量检测方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1562607A1 (fr) * 2002-11-15 2005-08-17 Ranbaxy Laboratories, Ltd. Formes galeniques pharmaceutiques de combinaisons de biguanide-sulfonyluree

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110801443A (zh) * 2019-12-03 2020-02-18 仁和堂药业有限公司 一种盐酸二甲双胍缓释制剂及其质量检测方法

Also Published As

Publication number Publication date
EP2001302A2 (fr) 2008-12-17
WO2007103563A2 (fr) 2007-09-13
WO2007103563A3 (fr) 2008-01-03

Similar Documents

Publication Publication Date Title
US20060088594A1 (en) Highly compressible controlled delivery compositions of metformin
RU2355386C2 (ru) Комплексная лекарственная форма с контролируемым высвобождением для перорального введения лекарственного средства против диабета и способ ее получения
US20040202718A1 (en) Dosage form for treatment of diabetes mellitus
TWI245632B (en) Solid oral dosage form comprising a combination of metformin and glibenclamide
JP4633329B2 (ja) スペーストドラッグデリバリーシステム
JP2022190162A (ja) グルコキナーゼ活性化剤およびｋ－ａｔｐチャネル遮断薬を含む医薬品の組合せ、組成物、配合剤、ならびにその調製方法および使用
US20070172525A1 (en) Anti-diabetic combinations
TW201206503A (en) Controlled release compositions with reduced food effect
WO2008050987A1 (fr) Formulation combinée à libération contrôlée comprenant de la metformine et du glimépiride
WO2021086292A1 (fr) Formulations de comprimés bicouches comprenant de la dapagliflozine et de la metformine
JP2011516544A (ja) ミチグリニドおよびメトホルミンの複合製剤並びにその製造方法
KR100709528B1 (ko) 혈당콘트롤용 의약조성물
US20030219482A1 (en) Multiparticulate compositions for once-a-day administration
WO2005107717A2 (fr) Forme pharmaceutique orale pour la liberation prolongee d'un biguanide et d'une sulfonyluree
WO2005105109A1 (fr) Pastilles a liberation orale modifiee et leur procede de preparation
CA2645318A1 (fr) Compositions pharmaceutiques contenant de la metformine
CN112716966B (zh) 一种恩格列净药用组合物及其制备方法
RU2273482C2 (ru) Фармацевтическая композиция с пролонгированным высвобождением гликлазида
WO2004002474A1 (fr) Composition medicamenteuse pour la prevention ou l'inhibition de la progression des complications du diabete
EP4212150A1 (fr) Composition de comprimé bicouche comprenant de la dapagliflozine amorphe et de la metformine
WO2023136797A2 (fr) Composition de comprimé bicouche comprenant de la metformine et de la dapagliflozine amorphe
WO2004091587A1 (fr) Liberation multiple de medicaments anti-diabete et procede de production associe
AU2002348712A1 (en) Dosage form for treatment of diabetes mellitus
WO2014154640A1 (fr) Formulations à libération contrôlée comprenant de la metformine et du gliclazide
TW200526271A (en) Composition for a modified-release oral tablet and method for manufacturing of the composition

Legal Events

Date Code Title Description
FZDE Discontinued